Fundraising Fox
Contera Pharma
Copenhagen, DK · Founded 2010 · 23 employees on LinkedIn · 1 known investors
Find your way into Contera Pharma
Each arrow is one introduction. Sign up to fill in the first one.
188 people can intro you to Thomas
Ask Jesper Gromada to introduce you to Thomas Sager
You →Jesper · together at Københavns Universitet - University of Copenhagen →Thomas
Sign up to find every way you can get introduced to Contera Pharma
- Your email: who you already know at Contera Pharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Contera Pharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.
Founders & leadership
TS
Thomas SagerCEOThomas Sager holds a PhD in Neuroscience from the University of Copenhagen and has held management positions at Lundbeck A/S before becoming CEO of Contera Pharma, a clinical-stage RNA medicines company, where he leads strategy and business development including licensing and M&A activities.
JB
John Bondo HansenFounder
MT
Mikael ThomsenFounder
Investors · 1
Related companies · 1
Companies working in the same space as Contera Pharma.
Frequently asked questions
- What does Contera Pharma do?
- Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.
- Who are Contera Pharma's investors?
- Contera Pharma's investors include SEED Capital Denmark.
- Where is Contera Pharma headquartered?
- Contera Pharma is headquartered in Copenhagen, DK.